FENC Earnings
Latest Revenue17.9M
Latest Net Income2.0M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.06 | 17.9M | 2.0M | +85.2% | +154.5% |
| Q1 2026 | $0.01 | 15.1M | 201.0K | +72.6% | +125.0% |
| Q4 2025 | -$0.15 | 13.8M | -4787000 | +73.8% | -114.3% |
| Q3 2025 | -$0.02 | 12.5M | -638000 | +78.7% | +90.5% |
| Q2 2025 | -$0.11 | 9.7M | -3152000 | +32.9% | +45.0% |
| Q1 2025 | -$0.04 | 8.8M | -1165000 | -65.5% | -108.5% |
| Q4 2024 | -$0.07 | 7.9M | -1985000 | -18.6% | +30.0% |
| Q3 2024 | -$0.21 | 7.0M | -5735000 | +7.0% | -200.0% |
| Q2 2024 | -$0.20 | 7.3M | -5553000 | — | — |
| Q1 2024 | $0.47 | 25.4M | 12.8M | — | — |
| Q4 2023 | -$0.10 | 9.7M | -2682000 | — | — |
| Q3 2023 | -$0.07 | 6.5M | -1867000 | — | — |
Fennec Pharmaceuticals (FENC) — Earnings